Currently out of the existing stock ratings of Jessica Tassan, 20 are a HOLD (25.32%), 4 are a SELL (5.06%), 55 are a BUY (69.62%).

Jessica Tassan

Work Performance Price Targets & Ratings Chart

Analyst Jessica Tassan works at PIPER SANDLER with a stock forecast success ratio of 38.9% fulfilled within 40.1 days on average.

Jessica Tassan’s has documented 169 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on HCAT, Health Catalyst at 23-Feb-2024.

Wall Street Analyst Jessica Tassan

Analyst best performing recommendations are on ACCD (ACCOLADE ).
The best stock recommendation documented was for HCAT (HEALTH CATALYST) at 9/13/2022. The price target of $11 was fulfilled within 1 day with a profit of $0.28 (2.61%) receiving and performance score of 26.12.

Average potential price target upside

CANO Cano Health CMAX CareMax HCAT Health Catalyst SGFY Signify Health TRHC Tabula Rasa HealthCare CHNG Change Healthcare EVH Evolent Health OMCL Omnicell OSH Oak Street Health PHR Phreesia TDOC Teladoc ALHC Alignment Healthcare LLC PRVA Privia Health Group AMWL American Well Corp DOCS Doximity MDRX Allscripts Healthcare Solutions ACCD Accolade  CVS CVS Health Corp NXGN Nextgen Healthcare PINC Premier UNH UnitedHealth Group orporated

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$11.72 (4185.71%)

4 months 26 days ago

0/1 (0%)

$4.37 (57.27%)



$0.25 (100.00%)


7 months 29 days ago

0/5 (0%)

$3.12 (70.54%)



$0.55 (220.00%)


8 months 1 days ago

0/3 (0%)

$3.48 (64.74%)



8 months 1 days ago

0/1 (0%)

$4.88 (40.26%)


1 years 9 days ago

4/4 (100%)

$2.26 (47.68%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Jessica Tassan is most bullish on?

Potential upside of $125 has been obtained for UNH (UNITEDHEALTH GROUP ORPORATED)

Which stock is Jessica Tassan is most reserved on?

Potential downside of -$5.68 has been obtained for CMAX (CAREMAX)

What Year was the first public recommendation made by Jessica Tassan?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?